Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease.
Ottinger EA, Kao ML, Carrillo-Carrasco N, Yanjanin N, Shankar RK, Janssen M, Brewster M, Scott I, Xu X, Cradock J, Terse P, Dehdashti SJ, Marugan J, Zheng W, Portilla L, Hubbs A, Pavan WJ, Heiss J, Vite CH, Walkley SU, Ory DS, Silber SA, Porter FD, Austin CP, McKew JC.
Ottinger EA, et al. Among authors: zheng w.
Curr Top Med Chem. 2014;14(3):330-9. doi: 10.2174/1568026613666131127160118.
Curr Top Med Chem. 2014.
PMID: 24283970
Free PMC article.
Review.